Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): A fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression

Journal of Molecular Diagnostics

Volumn 2, Issue 2, 2000, Pages 78-83

  Tubbs, Raymond R ^a   Pettay, James ^a   Roche, Pat ^b   Stoler, Mark H ^d   Jenkins, Robert ^b   Myles, Jon ^a   Grogan, Thomas ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; RNA;

ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PAGET NIPPLE DISEASE; PROTO ONCOGENE; VALIDATION STUDY;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; RECEPTOR, ERBB-2; RNA, NEOPLASM;

EID: 0034189057     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60620-4     Document Type: Article

References (13)

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
2. Slamon DJ, Godolphin W, Jones LA, Holt JA, Keith DE, Wong SG, Levin WJ, Stuart SG, Udove J, Ullrich A, Press M: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712
3. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996, 13:63-72
4. Press MF, Jones LA, Godolphin W. Edwards CL, Slamon DJ: HER-2/ neu oncogene amplification and expression in breast and ovarian cancers. Prog Clin Biol Res 1990, 209-221
5. Press MF, Hung G, Godolphin W, Slamon DJ: Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994, 54:2771-2777
6. Bukowski RM, Olencki T, Gunn H, McLain D, Budd GT, Sandstrom K, Tuason L, Redovan C, Rayman P, Tubbs R, Resta D, Elson P, Finke J: Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings. Clin Cancer Res 1996, 2:347-357
7. Segal GH, Stoler MH, Tubbs RR: The "CD43 only" phenotype: An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution. Am J Clin Pathol 1992, 97:861-865
8. Roche PC, Ingle JN: Increased Her-2 with US Food and Drug Administration approved antibody. J Clin Oncol 1999, 17:434-435
9. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ: Specificity of HercepTest in determining Her-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol 1999, 17:1983-1987
10. Tbakhi A, Pettay J, Sreenan JJ, Abdel-Razeq H, Kaylacio M, Hoeltge G, Miller ML, Tubbs RR: Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders. Am J Clin Pathol 1998, 109:16-23
11. Angerer LM SM, Angerer RC: In situ hybridization with RNA probes: an annotated recipe. In Situ Hybridization: Applications to Neurobiology. Edited by Valentino KEJ, Barchus J. New York, Oxford University Press, 1987, pp 42-70
12. Stoler MH: In situ hybridization. Clin Lab Med 1990, 10:215-236
13. Segal GH, Shick HE, Tubbs RR, Fishleder AJ, Stoler MH: In situ hybridization analysis of lymphoproliferative disorders: assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol 1994, 3:170-177